Evidence map›Paper›PMID 41071658›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

BTK autoinhibition analyzed by high-throughput swaps of SH2 domains.

Timothy J Eisen, Sam Ghaffari-Kashani, Chien-Lun Hung, Jay T Groves, John Kuriyan

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. BTK autoinhibition analyzed by high-throughput swaps of SH2 domains.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Timothy J EisenDepartment of Chemistry, University of California, Berkeley, CA 94720.ORCID 0000-0002-4812-4171
Sam Ghaffari-KashaniDepartment of Chemistry, University of California, Berkeley, CA 94720.
Chien-Lun HungDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37240.ORCID 0000-0002-2546-1132
Jay T GrovesDepartment of Chemistry, University of California, Berkeley, CA 94720.ORCID 0000-0002-3037-5220
John KuriyanDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37240.ORCID 0000-0002-4414-5477

Funding

Damon Runyon Cancer Research Foundation (DRCRF) DRG-2429-21HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) P01 A1091580
6 · The paper itself

Abstract

Bruton's Tyrosine Kinase (BTK), a Tec-family tyrosine kinase, resembles the Src and Abl kinases in that an SH2-SH3 module regulates the activity of the kinase domain, principally through an inhibitory interaction between the SH3 and kinase domains. In Src-family kinases, phosphorylation of a C-terminal tail latches the SH2 domain onto the kinase domain, stabilizing the inhibitory conformation of the SH3 domain; in Abl, interaction between the kinase domain and a myristoyl group on the N-terminal segment provides a similar latching function. The structure of autoinhibited BTK resembles that of the Src and Abl kinases, but BTK lacks an obvious SH2-kinase latch. To assess the role of the SH2 domain in autoinhibition of BTK, we generated hundreds of chimeric BTK molecules in which the native SH2 domain is replaced by other SH2 domains. We measured the fitness of these chimeric proteins using a high-throughput assay in T and B cells. Surprisingly, many SH2 domains increased fitness when substituted into BTK. Analysis of one set of chimeric proteins indicates that the increase in fitness stems from the ability of the substituted SH2 domains to disrupt BTK autoinhibition while maintaining phosphotyrosine targeting. Thus, although BTK lacks a specialized latch, distributed interactions between the SH2 and kinase domains stabilize the autoinhibitory conformation of BTK. While phosphotyrosine recognition can be conferred on BTK by evolutionarily distant SH2 domains, autoinhibition requires specific interactions with the kinase domain that arose through evolutionary refinement of the regulatory mechanism, and is less easily mimicked by heterologous SH2 domains.

Indexed as

Protein-Tyrosine Kinasessrc Homology DomainsAgammaglobulinaemia Tyrosine KinaseB-LymphocytesHumansPhosphorylationT-LymphocytesAgammaglobulinaemia Tyrosine KinaseBTK protein, humanProtein-Tyrosine KinasesB-cellsBTKkinasesSH2 domainsSrc module

Identifiers

PMID41071658
PMCPMC12541323

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.